Discovery and Developmental Therapeutics Discoveries and Accomplishments

The Discovery and Developmental Therapeutics Research Program works significantly on developing precision therapies, including targeted agents and immunotherapy. These efforts aim to impact the standard of care for patients in Georgia with a focus on lung cancer, breast cancer, colon cancer, prostate cancer, pancreatic cancer and multiple myeloma. These interventions are expected to reduce the significant cancer burden experienced in our state.

Recent program highlights showing the impact of the program include achievements in:

• New FDA-approved therapies for lung cancer
• A new standard of care for post-menopausal breast cancer
• New approaches for multiple myeloma

Additionally, program members actively engage with the patient community by serving on Medical Advisory Boards for patient-run tumor foundations and participating in outreach symposiums to inform the community about novel therapy approaches.

 

The Discovery and Developmental Therapeutics Research Program plays a pivotal role as a translational engine within Winship Cancer Institute of Emory University. By leveraging the expertise of its members, the program is poised to conduct innovative research aimed at discovering and developing new cancer therapeutics, ultimately reducing the burden of cancer and instilling hope in patients with cancer across Georgia.

Aligned with Winship's strategic plan, program members are currently prioritizing the following initiatives:

• Enrich innovative cancer drug discovery pipeline
• Leverage program leadership in national NCI-supported clinical initiatives to advance clinical development of novel therapeutics and approaches
• Continue to expand depth of research in imaging theme for novel diagnostics and treatment strategies
• Enhancing communication and collaborations for drug development and therapeutics